NFATc1: functions in osteoclasts
- PMID: 20035895
- DOI: 10.1016/j.biocel.2009.12.018
NFATc1: functions in osteoclasts
Abstract
NFATc1 is an important transcription factor which is critical for lineage selection in T-cell differentiation, cardiac valve morphogenesis, lymphatic endothelial development, osteoblast differentiation and osteoclastogenesis. Especially, it is a master regulator of RANKL-induced osteoclast differentiation and plays a pivotal role in osteoclast fusion and osteoclast activation via up-regulation of various genes responsible for osteoclast adhesion, migration, acidification, degradation of inorganic and organic bone matrix. In the present review, some of the known features of NFATc1 such as structure, function and its roles in physiological or pathophysiological processes are highlighted.
2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation.FEBS Lett. 2009 Jul 21;583(14):2435-40. doi: 10.1016/j.febslet.2009.06.047. Epub 2009 Jul 2. FEBS Lett. 2009. PMID: 19576893
-
Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.Biochem Biophys Res Commun. 2005 Apr 15;329(3):839-45. doi: 10.1016/j.bbrc.2005.02.049. Biochem Biophys Res Commun. 2005. PMID: 15752732
-
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.J Bone Miner Res. 2005 Apr;20(4):653-62. doi: 10.1359/JBMR.041213. Epub 2004 Dec 6. J Bone Miner Res. 2005. PMID: 15765185
-
The molecular understanding of osteoclast differentiation.Bone. 2007 Feb;40(2):251-64. doi: 10.1016/j.bone.2006.09.023. Epub 2006 Nov 13. Bone. 2007. PMID: 17098490 Review.
-
Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation.Immunol Rev. 2009 Sep;231(1):241-56. doi: 10.1111/j.1600-065X.2009.00821.x. Immunol Rev. 2009. PMID: 19754901 Review.
Cited by
-
A Comparison of the Antiosteoporotic Effects of Cornelian Cherry (Cornus mas L.) Extracts from Red and Yellow Fruits Containing Different Constituents of Polyphenols and Iridoids in Osteoblasts and Osteoclasts.Oxid Med Cell Longev. 2022 Oct 3;2022:4122253. doi: 10.1155/2022/4122253. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36225173 Free PMC article.
-
Do We Use Methylation of NFATC1 and FOS Genes As a Biomarker for Postmenopausal Osteoporosis?Balkan J Med Genet. 2021 Mar 23;23(2):35-40. doi: 10.2478/bjmg-2020-0021. eCollection 2020 Nov. Balkan J Med Genet. 2021. PMID: 33816070 Free PMC article.
-
Oat Seedlings Extract Inhibits RANKL-Induced c-Fos/NFATc1 Transcription Factors in the Early Stage of Osteoclast Differentiation.Evid Based Complement Alternat Med. 2022 Sep 23;2022:5372459. doi: 10.1155/2022/5372459. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36193131 Free PMC article.
-
FTY720 Attenuates LPS-Induced Inflammatory Bone Loss by Inhibiting Osteoclastogenesis via the NF-κB and HDAC4/ATF Pathways.J Immunol Res. 2023 Jan 6;2023:8571649. doi: 10.1155/2023/8571649. eCollection 2023. J Immunol Res. 2023. PMID: 36644540 Free PMC article.
-
Aspirin prevents estrogen deficiency-induced bone loss by inhibiting osteoclastogenesis and promoting osteogenesis.J Orthop Surg Res. 2023 Mar 22;18(1):227. doi: 10.1186/s13018-023-03710-y. J Orthop Surg Res. 2023. PMID: 36944992 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
